BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8634448)

  • 21. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
    Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
    Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes.
    Wong YYM; van der Vuurst de Vries RM; van Pelt ED; Ketelslegers IA; Melief MJ; Wierenga AF; Catsman-Berrevoets CE; Neuteboom RF; Hintzen RQ
    Mult Scler; 2018 Nov; 24(13):1715-1724. PubMed ID: 30019626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.
    Nagato T; Komatsuda H; Hayashi R; Takahara M; Kishibe K; Yasuda S; Yajima Y; Kosaka A; Ohkuri T; Oikawa K; Harabuchi S; Kono M; Yamaki H; Wakisaka R; Hirata-Nozaki Y; Ohara K; Kumai T; Katada A; Hayashi T; Harabuchi Y; Kobayashi H
    Cancer Immunol Immunother; 2023 Jul; 72(7):2087-2098. PubMed ID: 36811663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder.
    Liu B; Zhong X; Lu Z; Qiu W; Hu X; Wang H
    Neuroimmunomodulation; 2018; 25(4):185-192. PubMed ID: 30423585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terminal deoxynucleotidyl transferase (TdT)-positive cells in cerebrospinal fluid and development of overt CNS leukemia: a 5-year follow-up study in 113 children with a TdT-positive leukemia or non-Hodgkin's lymphoma.
    Hooijkaas H; Hählen K; Adriaansen HJ; Dekker I; van Zanen GE; van Dongen JJ
    Blood; 1989 Jul; 74(1):416-22. PubMed ID: 2752121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily.
    Molica S; Vitelli G; Levato D; Crispino G; Dell'Olio M; Dattilo A; Matera R; Gandolfo GM; Musto P
    Haematologica; 1998 May; 83(5):398-402. PubMed ID: 9658722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.
    Chamberlain MC; Glantz M; Groves MD; Wilson WH
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S35-45. PubMed ID: 19660682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Soluble interleukin-2 receptor and macrophage colony-stimulating factor (M-CSF) in cerebrospinal fluid in patients with hematological malignancies: clinical significance in adult T-cell leukemia with meningeal infiltration].
    Tanaka K; Shiraishi K; Sakamoto A; Fukahori S; Jojima H; Osabe S; Mizunoe K; Masuchi K; Imamura Y; Honda J; Egami K; Natori H; Oizumi K
    Rinsho Ketsueki; 1996 Jul; 37(7):610-7. PubMed ID: 8779781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and β2-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma.
    Maeyama M; Sasayama T; Tanaka K; Nakamizo S; Tanaka H; Nishihara M; Fujita Y; Sekiguchi K; Kohta M; Mizukawa K; Hirose T; Itoh T; Kohmura E
    Cancer Med; 2020 Jun; 9(12):4114-4125. PubMed ID: 32314548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus.
    Font J; Pallares L; Martorell J; Martinez E; Gaya A; Vives J; Ingelmo M
    Clin Immunol Immunopathol; 1996 Dec; 81(3):239-43. PubMed ID: 8938100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies.
    Bromberg JE; Breems DA; Kraan J; Bikker G; van der Holt B; Smitt PS; van den Bent MJ; van't Veer M; Gratama JW
    Neurology; 2007 May; 68(20):1674-9. PubMed ID: 17502548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk of neurological relapse in acute lymphoblastic leukemias with high levels of cerebrospinal fluid thymidine kinase at diagnosis.
    Musto P; Modoni S; Ladogana S; Salcuni G; Fusilli S; Carotenuto M
    Leuk Lymphoma; 1993 Jan; 9(1-2):121-4. PubMed ID: 8477191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein biomarker identification in the CSF of patients with CNS lymphoma.
    Roy S; Josephson SA; Fridlyand J; Karch J; Kadoch C; Karrim J; Damon L; Treseler P; Kunwar S; Shuman MA; Jones T; Becker CH; Schulman H; Rubenstein JL
    J Clin Oncol; 2008 Jan; 26(1):96-105. PubMed ID: 18056677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy.
    Jeffery GM; Frampton CM; Legge HM; Hart DN
    Pathology; 1990 Jan; 22(1):20-3. PubMed ID: 2194155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low levels of specific T cell activation marker CD27 accompanied by elevated levels of markers for non-specific immune activation in the cerebrospinal fluid of patients with AIDS dementia complex.
    Portegies P; Godfried MH; Hintzen RQ; Stam J; van der Poll T; Bakker M; van Deventer SJ; van Lier RA; Goudsmit J
    J Neuroimmunol; 1993; 48(2):241-7. PubMed ID: 8227320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
    Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma.
    Chang CS; Liu HW; Lin SF; Chen TP
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):132-7. PubMed ID: 2605973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: correlation with disease stage and prognosis.
    Kara IO; Sahin B; Gunesacar R
    Adv Ther; 2007; 24(1):29-40. PubMed ID: 17526459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-dimer levels in the cerebrospinal fluid: a marker of central nervous system involvement in neoplastic disease.
    Eclache V; Vu T; Le Roux G
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):321-4. PubMed ID: 7971253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk.
    Purdue MP; Lan Q; Hoffman-Bolton J; Hildesheim A; Callahan CL; Strickland P; Visvanathan K; Rothman N
    Int J Cancer; 2019 Apr; 144(8):1780-1785. PubMed ID: 30230539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.